OCTOBER 29 2024
In this inaugural episode of The Life Sciences GenAI Exchange podcast, host Jason Bryant is joined by Daniel Berglund, Partner and Co-Head of Healthcare, Nordic Capital Advisors, and Aman Wasan, CEO of Aris Global. Together, they explore the economic impact of generative AI and automation on life sciences research, streamlining R&D workflows and innovation.
The Life Sciences Gen AI Exchange podcast series investigates the transformative influence of generative AI and automation in the life sciences sector. Hosted by industry experts, each episode features thought leaders who analyse the latest technological advancements, emerging trends, and strategic investments shaping pharmaceutical R&D.
This first episode highlights how early adoption and solid technology partnerships can enable life sciences companies to streamline their workflows, enhance innovation, and maintain profitability amidst regulatory challenges.
Daniel emphasises the challenges posed by the Inflation Reduction Act, noting that reduced funding for R&D in the US, starting in 2026, will require significant efficiency improvements. Estimates suggest that major pharmaceutical companies may need to reduce their total cost base by 10-15%. The discussion also touches on data efficiency and Nordic Capital's investment strategy, among other relevant topics.
Follow this link to listen to the full episode: https://www.arisglobal.com/podcast